Trial Profile
A Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Chemotherapy and Androgen Pathway Inhibitors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Aciclovir; Dexamethasone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 10 Feb 2018 Results assessing safety and efficacy presented at the 2018 Genitourinary Cancers Symposium
- 23 Oct 2017 Status changed from active, no longer recruiting to completed.
- 19 May 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.